Psychedelic helps those with cancer cope, 2 new studies find
Researchers at the Johns Hopkins School of Medicine have found that a psychedelic drug can significantly reduce anxiety, depression and other emotional distress in cancer patients.
The patients experienced almost immediate relief, which lasted for months, after taking psilocybin, the active hallucinogenic ingredient in “magic mushrooms,” the researchers reported. A separate study by researchers at New York University’s Langone Medical Center found the same effect.
The findings are the latest in a growing body of research on how psychedelics can be used to treat various illnesses. Studies involving the drugs have resurged in recent years after being stymied for decades when the federal government deemed psychedelics a dangerous controlled substance and stopped funding the research.